Tat-functionalized Ag-FeO Nano-composites As Tissue-penetrating Vehicles for Tumor Magnetic Targeting and Drug Delivery
Overview
Authors
Affiliations
In this paper, we prepared a dual functional system based on dextrin-coated silver nanoparticles which were further attached with iron oxide nanoparticles and cell penetrating peptide (Tat), producing Tat-modified Ag-FeO nanocomposites (Tat-FeAgNPs). To load drugs, an -SH containing linker, 3-mercaptopropanohydrazide, was designed and synthesized. It enabled the silver carriers to load and release doxorubicin (Dox) in a pH-sensitive pattern. The delivery efficiency of this system was assessed using MCF-7 cells, and using null BalB/c mice bearing MCF-7 xenograft tumors. Our results demonstrated that both Tat and externally applied magnetic field could promote cellular uptake and consequently the cytotoxicity of doxorubicin-loaded nanoparticles, with the IC of Tat-FeAgNP-Dox to be 0.63 µmol/L. The delivery efficiency of Tat-FeAgNP carrying Cy5 to the mouse tumor was analyzed using the optical imaging tests, in which Tat-FeAgNP-Cy5 yielded the most efficient accumulation in the tumor (6.7±2.4% ID of Tat-FeAgNPs). Anti-tumor assessment also demonstrated that Tat-FeAgNP-Dox displayed the most significant tumor-inhibiting effects and reduced the specific growth rate of tumor by 29.6% ( = 0.009), which could be attributed to its superior performance in tumor drug delivery in comparison with the control nanovehicles.
Magneto-optical nanosystems for tumor multimodal imaging and therapy .
Wang M, Wang Y, Fu Q Mater Today Bio. 2024; 26:101027.
PMID: 38525310 PMC: 10959709. DOI: 10.1016/j.mtbio.2024.101027.
The Emerging Role of Ferroptosis in Sepsis, Opportunity or Challenge?.
Huang Q, Ding Y, Fang C, Wang H, Kong L Infect Drug Resist. 2023; 16:5551-5562.
PMID: 37641800 PMC: 10460599. DOI: 10.2147/IDR.S419993.
Zimina T, Sitkov N, Gareev K, Fedorov V, Grouzdev D, Koziaeva V Biosensors (Basel). 2022; 12(10).
PMID: 36290927 PMC: 9599632. DOI: 10.3390/bios12100789.
Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission.
Shipunova V, Belova M, Kotelnikova P, Shilova O, Mirkasymov A, Danilova N Pharmaceutics. 2022; 14(5).
PMID: 35631598 PMC: 9145338. DOI: 10.3390/pharmaceutics14051013.
Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer.
Benko A, Medina-Cruz D, Vernet-Crua A, OConnell C, Swietek M, Barabadi H Cancer Drug Resist. 2022; 4(2):264-297.
PMID: 35582024 PMC: 9019274. DOI: 10.20517/cdr.2020.81.